Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for refractory heel enthesitis in spondylarthropathy
2006-002749-35Phase 4Completed
- Sponsor
- Wyeth
- Start
- Nov 2006
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in spondyloarthritis (SpA) and enthesitis comparing Etanercept 50 mg once weekly with Placebo (2 arms). Started Nov 2006; status: completed.
02
Drugs
etanercept
03
Conditions
spondyloarthritis (SpA)enthesitis
Beyond the preview
Go deeper on 2006-002749-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002749-35.